Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor β is associated with lymphatic metastasis in human gastric carcinoma

Cancer Science

Volumn 101, Issue 9, 2010, Pages 1984-1989

  Kodama, Michiyo ^a   Kitadai, Yasuhiko ^a   Sumida, Tomonori ^a   Ohnishi, Mayu ^a   Ohara, Eiji ^a   Tanaka, Miwako ^a   Shinagawa, Kei ^a   Tanaka, Shinji ^b   Yasui, Wataru ^a   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; STROMA CELL;

AGED; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-SIS; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; STROMAL CELLS;

EID: 77955950139     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01639.x     Document Type: Article

References (30)

1. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3:453-8.
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-57.
3. Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev 2002, 82:673-700.
4. Karkkainen MJ, Haiko P, Sainio K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004, 5:74-80.
5. Makinen T, Jussila L, Veikkola T. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 2001, 7:199-205.
6. Mandriota SJ, Jussila L, Jeltsch M. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis. EMBO J 2001, 20:672-82.
7. Skobe M, Hawighorst T, Jackson DG. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001, 7:192-8.
8. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002, 2:573-83.
9. Kubo H, Cao R, Brakenhielm E, Makinen T, Cao Y, Alitalo K. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci U S A 2002, 99:8868-73.
10. Gale NW, Thurston G, Hackett SF. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 2002, 3:411-23.
11. Kajiya K, Hirakawa S, Ma B, Drinnenberg I, Detmar M. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 2005, 24:2885-95.
12. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005, 201:1089-99.
13. Cao R, Bjorndahl MA, Religa P. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 2004, 6:333-45.
14. Pietras K, Sjoblom T, Rubin K, Heldin CH, Ostman A. PDGF receptors as cancer drug targets. Cancer Cell 2003, 3:439-43.
15. Heldin CH, Eriksson U, Ostman A. New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys 2002, 398:284-90.
16. Li X, Eriksson U. Novel PDGF family members: PDGF-C and PDGF-D. Cytokine Growth Factor Rev 2003, 14:91-8.
17. Uehara H, Kim SJ, Karashima T. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. J Natl Cancer Inst 2003, 95:458-70.
18. Risau W, Drexler H, Mironov V. Platelet-derived growth factor is angiogenic in vivo. Growth Factors 1992, 7:261-6.
19. Ostman A. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 2004, 15:275-86.
20. Pietras K. Increasing tumor uptake of anticancer drugs with imatinib. Semin Oncol 2004, 31:18-23.
21. Japanese classification of gastric carcinoma 1999, Japanese Research Society for Gastric Cancer, Tokyo, Kanehara
22. Druker BJ, Tamura S, Buchdunger E. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996, 2:561-6.
23. Buchdunger E, Cioffi CL, Law N. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000, 295:139-45.
24. Hwang RF, Yokoi K, Bucana CD. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. Clin Cancer Res 2003, 9:6534-44.
25. Valencak J, Heere-Ress E, Kopp T, Schoppmann SF, Kittler H, Pehamberger H. Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer 2004, 40:358-64.
26. Folkman J. Looking for a good endothelial address. Cancer Cell 2002, 1:113-5.
27. Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002, 1:219-27.
28. Hida K, Hida Y, Amin DN. Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 2004, 64:8249-55.
29. Clasper S, Royston D, Baban D. A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res 2008, 68:7293-303.
30. Fidler IJ, Poste G. The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy. Semin Oncol 1985, 12:207-21.